Sparsentan(Filspari)

Another NamePS-433540, RE-021, DARA-a, 斯帕森坦,司帕生坦

IndicationsIt is indicated for slowing the decline in renal function in adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.